 | • レポートコード：QYR9ST01432 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の認知症薬市場について調査・分析し、以下の構成でお届け致します。認知症薬の種類別には、MAO阻害剤、コリンエステラーゼ阻害剤、グルタミン酸阻害剤に、用途別には、病院薬局、小売薬局、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別認知症薬売上データ ・地域別認知症薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別認知症薬市場規模：MAO阻害剤、コリンエステラーゼ阻害剤、グルタミン酸阻害剤 ・用途別認知症薬市場規模：病院薬局、小売薬局、その他 ・主要メーカーの企業情報：Eisai, Inc、Janssen Pharmaceuticals, Inc、Biogen Pharmaceuticals、Forest Laboratories, Inc、Eli Lilly and Company、Novartis AG、Sanofi S.A、AstraZeneca GmbH、F. Hoffmann-La Roche、Merck & Co., Inc、Valeant Pharmaceutical International、Pfizer Inc、Teva Pharmaceuticals Industries ・認知症薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
The global Dementia Drugs market is valued at 13900 million US$ in 2018 and will reach 26500 million US$ by the end of 2025, growing at a CAGR of 8.4% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dementia Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Dementia Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dementia Drugs in these regions.
This research report categorizes the global Dementia Drugs market by top players/brands, region, type and end user. This report also studies the global Dementia Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Eisai, Inc
Janssen Pharmaceuticals, Inc
Biogen Pharmaceuticals
Forest Laboratories, Inc
Eli Lilly and Company
Novartis AG
Sanofi S.A
AstraZeneca GmbH
F. Hoffmann-La Roche
Merck & Co., Inc
Valeant Pharmaceutical International
Pfizer Inc
Teva Pharmaceuticals Industries
Market size by Product
MAO Inhibitors
Cholinesterase Inhibitors
Glutamate Inhibitors
Market size by End User
Hospital Pharmacies
Retail Pharmacies
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Dementia Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Dementia Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Dementia Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Dementia Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Dementia Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dementia Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Dementia Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Dementia Drugs Market Size Growth Rate by Product
1.4.2 MAO Inhibitors
1.4.3 Cholinesterase Inhibitors
1.4.4 Glutamate Inhibitors
1.5 Market by End User
1.5.1 Global Dementia Drugs Market Size Growth Rate by End User
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Dementia Drugs Market Size
2.1.1 Global Dementia Drugs Revenue 2014-2025
2.1.2 Global Dementia Drugs Sales 2014-2025
2.2 Dementia Drugs Growth Rate by Regions
2.2.1 Global Dementia Drugs Sales by Regions
2.2.2 Global Dementia Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Dementia Drugs Sales by Manufacturers
3.1.1 Dementia Drugs Sales by Manufacturers
3.1.2 Dementia Drugs Sales Market Share by Manufacturers
3.1.3 Global Dementia Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Dementia Drugs Revenue by Manufacturers
3.2.1 Dementia Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Dementia Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Dementia Drugs Price by Manufacturers
3.4 Dementia Drugs Manufacturing Base Distribution, Product Types
3.4.1 Dementia Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dementia Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Dementia Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Dementia Drugs Sales by Product
4.2 Global Dementia Drugs Revenue by Product
4.3 Dementia Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Dementia Drugs Breakdown Data by End User
6 North America
6.1 North America Dementia Drugs by Countries
6.1.1 North America Dementia Drugs Sales by Countries
6.1.2 North America Dementia Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Dementia Drugs by Product
6.3 North America Dementia Drugs by End User
7 Europe
7.1 Europe Dementia Drugs by Countries
7.1.1 Europe Dementia Drugs Sales by Countries
7.1.2 Europe Dementia Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dementia Drugs by Product
7.3 Europe Dementia Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Dementia Drugs by Countries
8.1.1 Asia Pacific Dementia Drugs Sales by Countries
8.1.2 Asia Pacific Dementia Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Dementia Drugs by Product
8.3 Asia Pacific Dementia Drugs by End User
9 Central & South America
9.1 Central & South America Dementia Drugs by Countries
9.1.1 Central & South America Dementia Drugs Sales by Countries
9.1.2 Central & South America Dementia Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Dementia Drugs by Product
9.3 Central & South America Dementia Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Dementia Drugs by Countries
10.1.1 Middle East and Africa Dementia Drugs Sales by Countries
10.1.2 Middle East and Africa Dementia Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Dementia Drugs by Product
10.3 Middle East and Africa Dementia Drugs by End User
11 Company Profiles
11.1 Eisai, Inc
11.1.1 Eisai, Inc Company Details
11.1.2 Company Business Overview
11.1.3 Eisai, Inc Dementia Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Eisai, Inc Dementia Drugs Products Offered
11.1.5 Eisai, Inc Recent Development
11.2 Janssen Pharmaceuticals, Inc
11.2.1 Janssen Pharmaceuticals, Inc Company Details
11.2.2 Company Business Overview
11.2.3 Janssen Pharmaceuticals, Inc Dementia Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Janssen Pharmaceuticals, Inc Dementia Drugs Products Offered
11.2.5 Janssen Pharmaceuticals, Inc Recent Development
11.3 Biogen Pharmaceuticals
11.3.1 Biogen Pharmaceuticals Company Details
11.3.2 Company Business Overview
11.3.3 Biogen Pharmaceuticals Dementia Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Biogen Pharmaceuticals Dementia Drugs Products Offered
11.3.5 Biogen Pharmaceuticals Recent Development
11.4 Forest Laboratories, Inc
11.4.1 Forest Laboratories, Inc Company Details
11.4.2 Company Business Overview
11.4.3 Forest Laboratories, Inc Dementia Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Forest Laboratories, Inc Dementia Drugs Products Offered
11.4.5 Forest Laboratories, Inc Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Company Business Overview
11.5.3 Eli Lilly and Company Dementia Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Eli Lilly and Company Dementia Drugs Products Offered
11.5.5 Eli Lilly and Company Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Details
11.6.2 Company Business Overview
11.6.3 Novartis AG Dementia Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Novartis AG Dementia Drugs Products Offered
11.6.5 Novartis AG Recent Development
11.7 Sanofi S.A
11.7.1 Sanofi S.A Company Details
11.7.2 Company Business Overview
11.7.3 Sanofi S.A Dementia Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Sanofi S.A Dementia Drugs Products Offered
11.7.5 Sanofi S.A Recent Development
11.8 AstraZeneca GmbH
11.8.1 AstraZeneca GmbH Company Details
11.8.2 Company Business Overview
11.8.3 AstraZeneca GmbH Dementia Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 AstraZeneca GmbH Dementia Drugs Products Offered
11.8.5 AstraZeneca GmbH Recent Development
11.9 F. Hoffmann-La Roche
11.9.1 F. Hoffmann-La Roche Company Details
11.9.2 Company Business Overview
11.9.3 F. Hoffmann-La Roche Dementia Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 F. Hoffmann-La Roche Dementia Drugs Products Offered
11.9.5 F. Hoffmann-La Roche Recent Development
11.10 Merck & Co., Inc
11.10.1 Merck & Co., Inc Company Details
11.10.2 Company Business Overview
11.10.3 Merck & Co., Inc Dementia Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Merck & Co., Inc Dementia Drugs Products Offered
11.10.5 Merck & Co., Inc Recent Development
11.11 Valeant Pharmaceutical International
11.12 Pfizer Inc
11.13 Teva Pharmaceuticals Industries
12 Future Forecast
12.1 Dementia Drugs Market Forecast by Regions
12.1.1 Global Dementia Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Dementia Drugs Revenue Forecast by Regions 2019-2025
12.2 Dementia Drugs Market Forecast by Product
12.2.1 Global Dementia Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Dementia Drugs Revenue Forecast by Product 2019-2025
12.3 Dementia Drugs Market Forecast by End User
12.4 North America Dementia Drugs Forecast
12.5 Europe Dementia Drugs Forecast
12.6 Asia Pacific Dementia Drugs Forecast
12.7 Central & South America Dementia Drugs Forecast
12.8 Middle East and Africa Dementia Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dementia Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Dementia Drugs Product Picture
Table Dementia Drugs Market Segments
Table Key Manufacturers Dementia Drugs Covered
Table Global Dementia Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Dementia Drugs Sales Market Share by Product 2014-2025
Figure MAO Inhibitors Product Picture
Table Major Manufacturers of MAO Inhibitors
Figure Cholinesterase Inhibitors Product Picture
Table Major Manufacturers of Cholinesterase Inhibitors
Figure Glutamate Inhibitors Product Picture
Table Major Manufacturers of Glutamate Inhibitors
Table Global Dementia Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital Pharmacies
Figure Retail Pharmacies
Figure Others
Figure Dementia Drugs Report Years Considered
Figure Global Dementia Drugs Market Size 2014-2025 (Million US$)
Figure Global Dementia Drugs Sales 2014-2025 (K Units)
Table Global Dementia Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Dementia Drugs Sales by Regions 2014-2019 (K Units)
Table Global Dementia Drugs Sales Market Share by Regions 2014-2019
Figure Global Dementia Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Dementia Drugs Sales Market Share by Regions
Table Global Dementia Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Dementia Drugs Revenue Market Share by Regions 2014-2019
Figure Global Dementia Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Dementia Drugs Revenue Market Share by Regions
Table Global Dementia Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Dementia Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Dementia Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Dementia Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Dementia Drugs Revenue Share by Manufacturers (2014-2019)
Figure Dementia Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Dementia Drugs Price (2014-2019) (USD/Unit)
Table Dementia Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Dementia Drugs Product Type
Table Date of International Manufacturers Enter into Dementia Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Dementia Drugs Sales by Product (2014-2019) (K Units)
Table Global Dementia Drugs Sales Share by Product (2014-2019)
Figure Global Dementia Drugs Sales Market Share by Product (2014-2019)
Figure Global Dementia Drugs Sales Market Share by Product in 2018
Table Global Dementia Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Dementia Drugs Revenue Share by Product (2014-2019)
Figure Global Dementia Drugs Revenue Market Share by Product (2014-2019)
Figure Global Dementia Drugs Revenue Market Share by Product in 2018
Table Dementia Drugs Price by Product 2014-2019 (USD/Unit)
Table Global Dementia Drugs Sales by End User (2014-2019) (K Units)
Table Global Dementia Drugs Sales Share by End User (2014-2019)
Figure Global Sales Dementia Drugs Market Share by End User (2014-2019)
Figure Global Sales Dementia Drugs Market Share by End User in 2018
Figure North America Dementia Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Dementia Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Dementia Drugs Sales by Countries (2014-2019) (K Units)
Table North America Dementia Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Dementia Drugs Sales Market Share by Countries
Table North America Dementia Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Dementia Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Dementia Drugs Revenue Market Share by Countries
Figure United States Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Dementia Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Dementia Drugs Sales by Product (2014-2019) (K Units)
Table North America Dementia Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Dementia Drugs Market Share by Product
Table North America Dementia Drugs Sales by End User (2014-2019) (K Units)
Table North America Dementia Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Dementia Drugs Market Share by End User
Figure Europe Dementia Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Dementia Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Dementia Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Dementia Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Dementia Drugs Sales Market Share by Countries
Table Europe Dementia Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Dementia Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Dementia Drugs Revenue Market Share by Countries
Figure Germany Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Dementia Drugs Sales by Product (2014-2019) (K Units)
Table Europe Dementia Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Dementia Drugs Market Share by Product
Table Europe Dementia Drugs Sales by End User (2014-2019) (K Units)
Table Europe Dementia Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Dementia Drugs Market Share by End User
Figure Asia Pacific Dementia Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Dementia Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Dementia Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Dementia Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Dementia Drugs Sales Market Share by Countries
Table Asia Pacific Dementia Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Dementia Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Dementia Drugs Revenue Market Share by Countries
Figure China Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Dementia Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific Dementia Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Dementia Drugs Market Share by Product
Table Asia Pacific Dementia Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific Dementia Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Dementia Drugs Market Share by End User
Figure Central & South America Dementia Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Dementia Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Dementia Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Dementia Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Dementia Drugs Sales Market Share by Countries
Table Central & South America Dementia Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Dementia Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Dementia Drugs Revenue Market Share by Countries
Figure Brazil Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Dementia Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America Dementia Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Dementia Drugs Market Share by Product
Table Central & South America Dementia Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America Dementia Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Dementia Drugs Market Share by End User
Figure Middle East and Africa Dementia Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Dementia Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Dementia Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Dementia Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Dementia Drugs Sales Market Share by Countries
Table Middle East and Africa Dementia Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Dementia Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Dementia Drugs Revenue Market Share by Countries
Figure GCC Countries Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Dementia Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Dementia Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Dementia Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Dementia Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Dementia Drugs Market Share by Product
Table Middle East and Africa Dementia Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Dementia Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Dementia Drugs Market Share by End User
Table Eisai, Inc Company Details
Table Eisai, Inc Dementia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eisai, Inc Recent Development
Table Janssen Pharmaceuticals, Inc Company Details
Table Janssen Pharmaceuticals, Inc Dementia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Janssen Pharmaceuticals, Inc Recent Development
Table Biogen Pharmaceuticals Company Details
Table Biogen Pharmaceuticals Dementia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biogen Pharmaceuticals Recent Development
Table Forest Laboratories, Inc Company Details
Table Forest Laboratories, Inc Dementia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Forest Laboratories, Inc Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Dementia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly and Company Recent Development
Table Novartis AG Company Details
Table Novartis AG Dementia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis AG Recent Development
Table Sanofi S.A Company Details
Table Sanofi S.A Dementia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi S.A Recent Development
Table AstraZeneca GmbH Company Details
Table AstraZeneca GmbH Dementia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca GmbH Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Dementia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Merck & Co., Inc Company Details
Table Merck & Co., Inc Dementia Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck & Co., Inc Recent Development
Table Valeant Pharmaceutical International Company Details
Table Pfizer Inc Company Details
Table Teva Pharmaceuticals Industries Company Details
Table Global Dementia Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Dementia Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Dementia Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Dementia Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Dementia Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global Dementia Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Dementia Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Dementia Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Dementia Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global Dementia Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Dementia Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Dementia Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Dementia Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Dementia Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Dementia Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Dementia Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Dementia Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Dementia Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Dementia Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Dementia Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Dementia Drugs Value Chain
Table Dementia Drugs Customers List
Table Dementia Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
認知症および運動障害の治療の世界市場：市場規模・現状・予測 Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality change…- HIV薬の世界市場：インサイト・予測 HIV is a type of retrovirus that causes serious complications in humans. It generally spreads via the blood, semen, vaginal fluid, pre-ejaculate, or breast milk. The global market for HIV drugs is envisaged to surpass USD 19,000 million by 2019 owing to the recent rise in HIV patient population.One …
- 抗うつ薬の世界市場：インサイト・予測 Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. Antidepressants help maintain balance of various hormones and chemicals in the brain, which helps i…
- 精神疾患薬の世界市場：インサイト・予測 Mental Illness is a psychological anomaly that is reflected in patient’s behavior through disability, distress, or any conduct that is not considered as normal mental development. The causes of mental lllness are very diverse and often unclear in most cases.The global Mental Illness Drugs market is …
- 抗精神病薬の世界市場：インサイト・予測 Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder.During 2016, the second-generation antipsychotic dr…